Source abstract
Abstract
Biomaterials are extensively used to restore damaged tissues, in the forms of implants (e.g., tissue engineered scaffolds) or biomedical devices (e.g., pacemakers). Once in contact with the physiological environment, nanostructured biomaterials undergo modifications as a result of endogenous proteins binding to their surface. The formation of this macromolecular coating complex, known as “protein corona,” onto the surface of nanoparticles and its effect on cell–particle interactions are currently under intense investigation. In striking contrast, protein corona constructs within nanostructured porous tissue engineering scaffolds remain poorly characterized. As organismal systems are highly dynamic, it is conceivable that the formation of distinct protein corona on implanted scaffolds might itself modulate cell–extracellular matrix interactions. Here, it is reported that corona complexes formed onto the fibrils of engineered collagen scaffolds display specific, distinct, and reproducible compositions that are a signature of the tissue microenvironment as well as being indicative of the subject's health condition. Protein corona formed on collagen matrices modulated cellular secretome in a context‐specific manner ex vivo, demonstrating their role in regulating scaffold–cellular interactions. Together, these findings underscore the importance of custom‐designing personalized nanostructured biomaterials, according to the biological milieu and disease state. The use of protein corona as in situ biosensor of temporal and local biomarkers is proposed.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Polymer Surface Interaction Studies · Collagen: Extraction and Characterization
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Stanford Cardiovascular Institute Stanford CA 94305 USA
Department of Pediatrics Stanford University 300 Pasteur Dr. Stanford CA 94305 USA
Division of Cardiovascular Medicine Stanford University 300 Pasteur Dr. Stanford CA 94305 USA
Sanford‐Burnham Medical Research Institute 10901 N. Torrey Pines Road La Jolla CA 92037 USA
Biomaterials and Advanced Drug Delivery Laboratory Stanford University 300 Pasteur Dr. Stanford CA 94305 USA
Proteomics Facility Sanford‐Burnham Medical Research Institute La Jolla CA 92037 USA
Department of Cardiothoracic Surgery Stanford University Medical Center Stanford CA 94305 USA
References (46)
Show source-provided references
15. M. Mahmoudi S. Bonakdar M. A. Shokrgozar H. Aghaverdi R. Hartmann A. Pick G. Witte W. J. Parak ACS Nano2013 7 8379.
10.1021/nn403844q ↗28. Binder B. R. · News Physiol. Sci. Int. J. Physiol. Prod. Jointly Int. Union Physiol. Sci. Am. Physiol. Soc. · 2002 · 17 · 56
40. Artym V. V. · Curr. Protoc. Cell Biol. · 2010 · 10 · 1